Your browser doesn't support javascript.
loading
CAR-iNKT cells targeting clonal TCRVß chains as a precise strategy to treat T cell lymphoma.
Rowan, Aileen G; Ponnusamy, Kanagaraju; Ren, Hongwei; Taylor, Graham P; Cook, Lucy B M; Karadimitris, Anastasios.
Afiliação
  • Rowan AG; Section of Virology, Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Ponnusamy K; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Ren H; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Taylor GP; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Cook LBM; Section of Virology, Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Karadimitris A; National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom.
Front Immunol ; 14: 1118681, 2023.
Article em En | MEDLINE | ID: mdl-36936927

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Leucemia-Linfoma de Células T do Adulto / Linfoma de Células T / Linfoma de Células T Periférico / Células T Matadoras Naturais / Receptores de Antígenos Quiméricos Limite: Adult / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Leucemia-Linfoma de Células T do Adulto / Linfoma de Células T / Linfoma de Células T Periférico / Células T Matadoras Naturais / Receptores de Antígenos Quiméricos Limite: Adult / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido